Cryoport, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Cryoport, Inc. (NASDAQ: CYRX) on May 5, 2021, covering events occurring on April 30, 2021. The filing details the results of the Company's 2021 Annual Meeting of Stockholders.
Key Financial Metrics
The filing text does not provide specific financial metrics such as revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and equity plan amendments.
Material Changes and Voting Results
Stockholders approved four key proposals at the Annual Meeting:
- Proposal 1 (Election of Directors): All eight nominees were elected. Notably, Robert Hariri, M.D., Ph.D., received significant opposition with 26,014,132 votes withheld compared to 15,575,738 votes for. Other directors received strong support with over 38 million votes each.
- Proposal 2 (Auditor Ratification): Stockholders approved the ratification of Ernst & Young LLP as the independent registered public accounting firm for the year ending December 31, 2021.
- Proposal 3 (Executive Compensation): The advisory vote to approve the compensation of named executive officers was approved.
- Proposal 4 (Equity Plan Amendment): Stockholders approved an amendment to the 2018 Omnibus Equity Incentive Plan, increasing the number of authorized shares available for issuance from 5,000,000 to 7,850,000.
Guidance, Outlook, and Risks
The filing does not contain management commentary on future guidance, outlook, or specific risk factors. The primary disclosure relates to the successful amendment of the equity incentive plan, which is attached as Exhibit 10.1.
Key Facts for Investor Verification
- Verify the impact of the increased equity pool (7.85 million shares) on potential future dilution.
- Review the specific reasons for the high number of votes withheld for director nominee Robert Hariri, M.D., Ph.D.
- Confirm the full terms of the amended 2018 Omnibus Equity Incentive Plan in Exhibit 10.1.
- Note that this filing does not include updated financial performance data; refer to the most recent 10-Q or 10-K for financial metrics.